Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Goldman Sachs Group (NY: GS )

485.33 -6.66 (-1.35%)
Streaming Delayed Price Updated: 12:59 PM EDT, Oct 3, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 579,042
Open 489.93
Bid (Size) 485.35 (2)
Ask (Size) 485.79 (1)
Prev. Close 491.99
Today's Range 484.20 - 490.50
52wk Range 289.36 - 517.26
Shares Outstanding 343,446,784
Dividend Yield 2.27%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Looking Into Goldman Sachs Gr's Recent Short Interest
Via Benzinga
Stock-Split Watch: Is Microsoft Next?
Will Microsoft split its stock again? Here's why you shouldn't hold your breath waiting for that announcement. 
Via The Motley Fool

Performance

YTD
+24.99%
+24.99%
1 Month
-0.44%
-0.44%
3 Month
+3.72%
+3.72%
6 Month
+17.23%
+17.23%
1 Year
+58.54%
+58.54%

More News

Read More
Is It Too Late to Buy Nvidia Stock? Wall Street's Answer May Surprise Investors
Via The Motley Fool
Expert Outlook: Goldman Sachs Gr Through The Eyes Of 14 Analysts
Via Benzinga
Nebius Group Provides Corporate Update
Via NewMediaWire
Topics Artificial Intelligence
Exposures Artificial Intelligence
TechMediaBreaks – Meta Platforms Inc. (NASDAQ: META) Partners with UK Banks to Enhance Fraud Detection
Via Investor Brand Network
Topics Fraud
Exposures Legal
Price Over Earnings Overview: Goldman Sachs Gr
Via Benzinga
$1000 Invested In Goldman Sachs Gr 5 Years Ago Would Be Worth This Much Today
Via Benzinga
10 Financials Stocks Whale Activity In Today's Session
Via Benzinga
Broadcom Stock Split Update: Up 3% Since June, History Says the AI Stock Will Do This Next
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Wells Fargo, Citigroup, Goldman Sachs Poised For Gains Amid Fed Rate Cuts - Morgan Stanley
Via Benzinga
Topics Economy
Exposures Interest Rates
Top 7 Takeaways From Milken, TOKEN2049, And F1 Singapore: Why Experts Say 'Diversify Into Asia'
Via Benzinga
These Are The Top Five Dow Stocks This Year Heading Into The Fourth Quarter
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
The Era of Cross-Chain Memes Has Arrived: In-Depth Analysis of PIKA Launchpad’s Dark Horse Potential
Via Binary News Network
Topics ETFs
A Once-in-a-Decade Opportunity: 2 AI Stocks to Buy Before They Soar 175% and 560%, According to Certain Wall Street Analysts
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
US Stocks Defy Odds, Reach New Milestones Amid Economic Volatility
Via Benzinga
Topics Economy
Exposures Economy Interest Rates
U.S. Electricity Demand is Exploding: 3 Stocks to Play its Monster Growth
Via The Motley Fool
3 Brilliant AI Stocks Billionaires Are Buying for the 3 Stages of the Artificial Intelligence Boom
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
AI Boom and Rate Cuts Boost Utility Stocks: Best Growth Picks
Via MarketBeat
Topics Artificial Intelligence Economy Energy
Exposures Artificial Intelligence Fossil Fuels Interest Rates
The Best Warren Buffett Stocks to Buy With $3,000 Right Now
Via The Motley Fool
BioMarin Stands Firm on 2027 Revenue Target Amid Ascendis Competition, Goldman Sachs Analyst Remains Bullish
Via Benzinga
What's In Store For Nike In Q1? Analyst Highlights China Vs. North America Trends
Via Benzinga
On the Heels of Inflation, Why Experts Expect Gold Prices Will Climb to Record Highs in 2025
Via FinancialNewsMedia
Topics Economy World Trade
Exposures Interest Rates Tariff
Private Equity Firms Circle Sanofi's Consumer Health Business Amid Potential Spinoff
Via Benzinga
Goldman Sachs Bullish On Avidity Biosciences, Cites Scalable RNA Therapeutics Platform For Rare Diseases
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.